Form 8-K - Current report:
SEC Accession No. 0000950170-25-065031
Filing Date
2025-05-07
Accepted
2025-05-07 08:05:23
Documents
14
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iron-20250507.htm   iXBRL 8-K 46604
2 EX-99.1 iron-ex99_1.htm EX-99.1 129815
3 GRAPHIC img57926557_0.jpg GRAPHIC 65482
4 GRAPHIC img57926557_1.jpg GRAPHIC 65482
  Complete submission text file 0000950170-25-065031.txt   485558

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20250507.xsd EX-101.SCH 26027
16 EXTRACTED XBRL INSTANCE DOCUMENT iron-20250507_htm.xml XML 4922
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 25919397
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)